Seoul Pharma Co. Ltd (018680) — Financial Flexibility Index
Seoul Pharma Co. Ltd (018680) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of ₩-2.51 Billion (operating CF ₩-2.66 Billion minus capex ₩145.86 Million) represents 0% of total liabilities (₩32.70 Billion). Check asset allocation strategy of Seoul Pharma Co. Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Seoul Pharma Co. Ltd Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Seoul Pharma Co. Ltd across 13 annual periods. See Seoul Pharma Co. Ltd (018680) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Seoul Pharma Co. Ltd (2012–2024)
Year-by-year free cash flow to debt coverage for Seoul Pharma Co. Ltd. For the full company profile including market capitalisation, see market value of Seoul Pharma Co. Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | ₩-778.75 Million | ₩-3.01 Billion | ₩31.45 Billion | ▼ -108.6% |
| 2023 | 0.29x | ₩7.16 Billion | ₩5.26 Billion | ₩24.74 Billion | ▲ +540.1% |
| 2022 | 0.05x | ₩1.22 Billion | ₩-78.21 Million | ₩27.01 Billion | ▲ +486.0% |
| 2021 | -0.01x | ₩-506.98 Million | ₩-1.67 Billion | ₩43.29 Billion | ▼ -106.6% |
| 2020 | 0.18x | ₩6.41 Billion | ₩5.74 Billion | ₩36.23 Billion | ▲ +143.3% |
| 2019 | 0.07x | ₩3.09 Billion | ₩2.93 Billion | ₩42.44 Billion | ▲ +566.2% |
| 2018 | -0.02x | ₩-627.68 Million | ₩-1.23 Billion | ₩40.25 Billion | ▼ -210.3% |
| 2017 | 0.01x | ₩467.39 Million | ₩-1.14 Billion | ₩33.08 Billion | ▼ -83.5% |
| 2016 | 0.09x | ₩4.33 Billion | ₩-1.89 Billion | ₩50.47 Billion | ▲ +49.5% |
| 2015 | 0.06x | ₩2.82 Billion | ₩1.42 Billion | ₩49.15 Billion | ▼ -33.0% |
| 2014 | 0.09x | ₩4.10 Billion | ₩1.48 Billion | ₩47.88 Billion | ▼ -66.8% |
| 2013 | 0.26x | ₩10.11 Billion | ₩-425.00 Million | ₩39.17 Billion | ▼ -66.5% |
| 2012 | 0.77x | ₩27.17 Billion | ₩9.22 Billion | ₩35.29 Billion | — |